Literature DB >> 29655307

The importance of melanoma inhibitory activity gene family in the tumor progression of oral cancer.

Tomonori Sasahira1, Anja Katrin Bosserhoff2, Tadaaki Kirita3.   

Abstract

Oral squamous cell carcinoma has a high potential for locoregional invasion and nodal metastasis. Consequently, early detection of such malignancies is of immense importance. The melanoma inhibitory activity (MIA) gene family comprises MIA, MIA2, transport and Golgi organization protein 1 (TANGO), and otoraplin (OTOR). These members of the MIA gene family have a highly conserved Src homology 3 (SH3)-like structure. Although the molecules of this family share 34-45% amino acid homology and 47-59% cDNA sequence homology, those members, excluding OTOR, play different tumor-associated functions. MIA has a pivotal role in the progression and metastasis of melanoma; MIA2 and TANGO have been suggested to possess tumor-suppressive functions; and OTOR is uniquely expressed in cochlea of the inner ear. Therefore, the definite functions of the MIA gene family in cancer cells remain unclear. Since the members of the MIA gene family are secreted proteins, these molecules might be useful tumor markers that can be detected in the body fluids, including serum and saliva. In this review, we described the molecular biological functions of the MIA gene family in oral cancer.
© 2018 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  MIA; MIA2; TANGO; oral cancer

Mesh:

Substances:

Year:  2018        PMID: 29655307     DOI: 10.1111/pin.12672

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  10 in total

1.  Identification of oral squamous cell carcinoma markers MUC2 and SPRR1B downstream of TANGO.

Authors:  Tomonori Sasahira; Miyako Kurihara-Shimomura; Hiroyuki Shimomura; Anja Katrin Bosserhoff; Tadaaki Kirita
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-23       Impact factor: 4.553

Review 2.  Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma.

Authors:  Tomonori Sasahira; Tadaaki Kirita
Journal:  Int J Mol Sci       Date:  2018-08-16       Impact factor: 5.923

3.  Sushi Repeat Containing Protein X-linked 2 Is a Downstream Signal of LEM Domain Containing 1 and Acts as a Tumor-Promoting Factor in Oral Squamous Cell Carcinoma.

Authors:  Tomonori Sasahira; Miyako Kurihara-Shimomura; Yukiko Nishiguchi; Hiroyuki Shimomura; Tadaaki Kirita
Journal:  Int J Mol Sci       Date:  2020-05-22       Impact factor: 5.923

4.  Prognostic Value of Lactate Dehydrogenase, Melanoma Inhibitory Protein, and S-100B Protein in Patients with Malignant Melanoma.

Authors:  Shuwen Fan; Xiao Liu; Yizhu Wu; Ke Li; Xiaoyu Zhao; Wei Lin; Jianjiang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-04       Impact factor: 2.650

5.  SERPINE2 is an oral cancer-promoting factor that induces angiogenesis and lymphangiogenesis.

Authors:  Tomonori Sasahira; Miyako Kurihara-Shimomura; Hiroyuki Shimomura; Tadaaki Kirita
Journal:  Int J Clin Oncol       Date:  2021-06-25       Impact factor: 3.402

6.  Non-SMC Condensin I Complex Subunit H (NCAPH) Is Associated with Lymphangiogenesis and Drug Resistance in Oral Squamous Cell Carcinoma.

Authors:  Hiroyuki Shimomura; Tomonori Sasahira; Chie Nakashima; Miyako Kurihara-Shimomura; Tadaaki Kirita
Journal:  J Clin Med       Date:  2019-12-27       Impact factor: 4.241

7.  Suppression of KIF22 Inhibits Cell Proliferation and Xenograft Tumor Growth in Tongue Squamous Cell Carcinoma.

Authors:  Yi Liu; Rong-Hua Li; Gang Ren; Jin Jiang
Journal:  Biomed Res Int       Date:  2020-01-21       Impact factor: 3.411

8.  Prognostic Indicators of Oral Squamous Cell Carcinoma.

Authors:  Girish Mysore Suresh; Ravi Koppad; B V Prakash; K S Sabitha; P S Dhara
Journal:  Ann Maxillofac Surg       Date:  2019 Jul-Dec

Review 9.  Searching for New Molecular Targets for Oral Squamous Cell Carcinoma with a View to Clinical Implementation of Precision Medicine.

Authors:  Tomonori Sasahira; Miyako Kurihara-Shimomura; Yudai Shimojjukoku; Kaori Shima; Tadaaki Kirita
Journal:  J Pers Med       Date:  2022-03-07

10.  Serine hydroxymethyltransferase 2 (SHMT2) potentiates the aggressive process of oral squamous cell carcinoma by binding to interleukin enhancer-binding factor 2 (ILF2).

Authors:  Hui Zhang; Yilei Che; Bin Xuan; Xiaozhen Wu; Hui Li
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.